Funding Opportunity: Genomic Technologies Pilot Grant RFA
The Duke School of Medicine Precision Genomics Collaboratory in collaboration with the Duke Center for Advanced Genomic Technologies is pleased to announce pilot grant funding to investigators to develop and/or apply genomic technologies to significant questions in the study or treatment of human disease. Proposals should include details about the technology to be developed or used including the novelty of the proposed application, the human disease relevance or how proposed non-human models relate to human disease, any foundational or supporting studies/data, and a summary of the potential impact including how the pilot grant will support follow-on funding.
These pilot grants are open to investigators at all stages in their career. We anticipate awarding 2-3 grants of up to $20,000 each for a duration of one year.
Potential representative topics that align with this RFP include:
- Genetic screening technologies
- Integrating chemical screening and drug screening with genomics/epigenomics
- Functional annotation of the non-coding genome or genes of unknown function
- Gene delivery, genome editing, or other manipulation of the genome, epigenome, or transcriptome
- High-throughput cell reprogramming or engineering of cellular or animal models of disease
- Sequencing and single-cell characterization technologies
- Computational and bioinformatic approaches to analyzing and visualizing related datasets
We are particularly interested in proposals that build new collaborations and/or new teams that might lead to extended productive and externally funded collaborations.
Deadline: November 30, 2021